期刊文献+

不同时间窗尿激酶溶栓治疗急性脑梗死对照研究的Meta分析 被引量:4

Meta-analysis of comparative study of thrombolytic therapy for acute cerebral infarction with urokinase between various time window
下载PDF
导出
摘要 目的 :了解尿激酶不同时间窗溶栓治疗急性脑梗死 (ACI)疗效的差异。方法 :应用Meta分析方法对在不同时间窗内使用尿激酶溶栓治疗ACI的 9项对照研究进行同质性检验和合并效应量的检验。结果 :①同质性检验 :χ2 =6 .12 74 ,自由度为 8,P >0 .0 5。②合并效应量的检验 :OR合并 =3.0 2 0 6 ,OR合并95 %可信区间为 1.776 1~ 5 .1371。OR合并 的检验 :χ2 =16 .6 4 79,P <0 .0 0 1。结论 :尿激酶 6h内溶栓治疗ACI的疗效显著优于 6h后的疗效。 Objective:To understand the difference of thrombolytic therapy for acute cerebral infarction with urokinase between various time window. Methods:9 studies, which compared the differences in effects of thrombolytic therapy for acute cerebral infarction with urokinase between various time windows, were analyzed with meta-analysis by approaches of homogeneity test and combined test. Results:(1)Homogeneity test shows that the cited studies are homogeneous with χ 2 =6.1274,P>0.05;and (2)combined test shows that the combined OR= 3.0206 and its 95% confidence interval was between1.7761~5.1371(χ 2=16.6479,P<0.001). Conclusion:The therapeutic effects of thrombolytic therapy with urokinase within 6 hours after onset of the symptom for acute cerebral infarction is significantly superior to those after 6 hours after onset of the symptom.
出处 《军医进修学院学报》 CAS 2004年第1期68-70,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 尿激酶 溶栓治疗 急性脑梗死 META分析 ACI 血栓溶解疗法 cerebral infarction,acute urinary plasminogenactivator thrombolytic therapy time window Meta-analysis
  • 相关文献

参考文献15

二级参考文献85

共引文献469

同被引文献37

  • 1杨瑞民,张铭秋,赵东菊,李奋保.急性脑梗死溶栓治疗的时间窗及其影响因素分析[J].介入放射学杂志,2005,14(5):465-467. 被引量:16
  • 2曹辉,许红芳,郝奇志,等.糖尿病并急性脑梗死预后与血糖水平的关系的研究[J].河南实用神经疾病杂志,2000,3(6):20-21.
  • 3蒋有金 延文秀.糖尿病并发脑梗死预后与血糖水平的关系.中国乡村医药,2000,7(5):17-17.
  • 4Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke[J]. Arch Neurol,2001,58(8) :1209-1212.
  • 5The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333(24):1581-1587.
  • 6Rajane C,Lisboa M,Borko D,et al.Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke[J].Stroke,2002,33(10):2866-2871.
  • 7Gregory J,Zoppo del,Randall T,et al.PROACT:a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke[J].Stroke,1998,29(1):4-11.
  • 8Randall T,Higashida MD,Anthony J,et al.Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke[J].Stroke,2003,34(8):e109.
  • 9Purdy PD,Devous MD,Batjer HH,et al.Microfibrillar collagen model of canine cerebral infarction[J].Stroke,1989,20(10):1361-1367.
  • 10Touzani O,Roussel S,MacKenzie ET.The ischaemic penumbra[J].Curr Opin Neurol,2001,14(3):83-88.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部